Validation of Galen Prostate and Galen Breast AI solutions in a Japanese cohort

Back

Prostate and breast cancer incidence rates have risen in Japan, emphasizing the need for precise histopathological diagnosis to determine patient prognosis and guide treatment decisions. Artificial intelligence algorithms have entered the clinical routine to increase precision and efficacy in patient care with growing malignancy numbers every year.

This study aimed to validate the performance and clinical utility of two artificial intelligence solutions, Galen Prostate and Galen Breast in detecting prostate and breast cancer in real-world clinical routine use in a Japanese cohort, also assessing their grading capabilities.

Click here to download the study:

Back

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

About IBEX

IBEX is the leader in AI-powered cancer diagnostics in pathology. We empower physicians to provide every patient with an accurate, timely and personalized cancer diagnosis. Our AI platform is deployed worldwide, supporting pathologists and providers with AI-insights that help improve the quality and accuracy of diagnosis, reduce turnaround times and boost productivity.

By providing my details I agree to the IBEX-AI Terms and conditions and Privacy policy. I also agree to receive emails form IBEX-AI and I understand that I may opt out of IBEX-AI subscriptions at any time.

How is artificial intelligence rising to the challenge in breast cancer diagnosis?

How ‘game-changing’ AI is helping discover cancer for the first time in UK | ITV News

The AI revolution in cancer diagnostics with Joseph Mossel, CEO of Ibex Medical Analytics